GoKawiil
Tech News
A new report cited by MIT Technology Review's The Checkup newsletter finds that global cases of anorexia nervosa and bulimia nervosa increased 71% between 1990 and 2023. Clinicians quoted in the report say they are already observing GLP-1 weight-loss drugs worsening disordered eating in some patients.
Clinical psychologist Cheri Levinson of the University of Louisville says she is seeing more eating disorder patients with more severe symptoms than at any point in her nearly 20-year career, including growing numbers misusing GLP-1 weight-loss drugs. Separately, a study in JAMA Psychiatry led by Ruhai Bai of Children's Hospital of Nanjing Medical University estimated the incidence of anorexia and bulimia across 204 countries and territories from 1990 to 2023, finding rising global health burden from these conditions.